Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome

Metabolic syndrome is a constellation of risk factors including hypertension, dyslipidemia, insulin resistance, and obesity that promote the development of cardiovascular disease. Metabolic syndrome has been associated with changes in the secretion or metabolism of glucocorticoids, which have import...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schnackenberg, Christine G., Costell, Melissa H., Krosky, Daniel J., Cui, Jianqi, Wu, Charlene W., Hong, Victor S., Harpel, Mark R., Willette, Robert N., Yue, Tian-Li
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3613092/
https://ncbi.nlm.nih.gov/pubmed/23586038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/427640
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky